180 related articles for article (PubMed ID: 29120820)
1. Development of PEGylated aspartic acid-modified liposome as a bone-targeting carrier for the delivery of paclitaxel and treatment of bone metastasis.
Yamashita S; Katsumi H; Hibino N; Isobe Y; Yagi Y; Tanaka Y; Yamada S; Naito C; Yamamoto A
Biomaterials; 2018 Feb; 154():74-85. PubMed ID: 29120820
[TBL] [Abstract][Full Text] [Related]
2. Dendrimer-based micelles with highly potent targeting to sites of active bone turnover for the treatment of bone metastasis.
Yamashita S; Katsumi H; Shimizu E; Nakao Y; Yoshioka A; Fukui M; Kimura H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2020 Dec; 157():85-96. PubMed ID: 33039547
[TBL] [Abstract][Full Text] [Related]
3. Development of PEGylated carboxylic acid-modified polyamidoamine dendrimers as bone-targeting carriers for the treatment of bone diseases.
Yamashita S; Katsumi H; Hibino N; Isobe Y; Yagi Y; Kusamori K; Sakane T; Yamamoto A
J Control Release; 2017 Sep; 262():10-17. PubMed ID: 28710004
[TBL] [Abstract][Full Text] [Related]
4. Dendritic poly(ethylene glycol) bearing paclitaxel and alendronate for targeting bone neoplasms.
Clementi C; Miller K; Mero A; Satchi-Fainaro R; Pasut G
Mol Pharm; 2011 Aug; 8(4):1063-72. PubMed ID: 21608527
[TBL] [Abstract][Full Text] [Related]
5. Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: in vitro and in vivo evaluation.
Fu YC; Fu TF; Wang HJ; Lin CW; Lee GH; Wu SC; Wang CK
Acta Biomater; 2014 Nov; 10(11):4583-4596. PubMed ID: 25050775
[TBL] [Abstract][Full Text] [Related]
6. Poly(ethylene glycol)-paclitaxel-alendronate self-assembled micelles for the targeted treatment of breast cancer bone metastases.
Miller K; Clementi C; Polyak D; Eldar-Boock A; Benayoun L; Barshack I; Shaked Y; Pasut G; Satchi-Fainaro R
Biomaterials; 2013 May; 34(15):3795-806. PubMed ID: 23434349
[TBL] [Abstract][Full Text] [Related]
7. DOPA-based paclitaxel-loaded liposomes with modifications of transferrin and alendronate for bone and myeloma targeting.
Chang Q; Geng R; Wang S; Qu D; Kong X
Drug Deliv; 2016 Nov; 23(9):3629-3638. PubMed ID: 27749106
[TBL] [Abstract][Full Text] [Related]
8. Peptide ligand and PEG-mediated long-circulating liposome targeted to FGFR overexpressing tumor in vivo.
Cai L; Wang X; Wang W; Qiu N; Wen J; Duan X; Li X; Chen X; Yang L; Qian Z; Wei Y; Chen L
Int J Nanomedicine; 2012; 7():4499-510. PubMed ID: 22923988
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and evaluation of liposomes modified with dendritic aspartic acid for bone-specific targeting.
Zhao Z; Chen C; Xie C; Zhao Y
Chem Phys Lipids; 2020 Jan; 226():104832. PubMed ID: 31560875
[TBL] [Abstract][Full Text] [Related]
10. Bone-targeting dendrimer for the delivery of methotrexate and treatment of bone metastasis.
Yamashita S; Katsumi H; Sakane T; Yamamoto A
J Drug Target; 2018 Nov; 26(9):818-828. PubMed ID: 29376757
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of cell penetrating peptide TAT and cleavable PEGco-modified liposomes loaded with paclitaxel and its in vitro apoptosis assay].
Fu H; Hu GL; He Q
Yao Xue Xue Bao; 2014 Jul; 49(7):1054-61. PubMed ID: 25233640
[TBL] [Abstract][Full Text] [Related]
12. Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs.
Tang H; Xie Y; Zhu M; Jia J; Liu R; Shen Y; Zheng Y; Guo X; Miao D; Pei J
Int J Nanomedicine; 2022; 17():3013-3041. PubMed ID: 35836838
[TBL] [Abstract][Full Text] [Related]
13. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K
Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344
[TBL] [Abstract][Full Text] [Related]
14. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
[TBL] [Abstract][Full Text] [Related]
15. Effect of Liposomes with Different Double Arms Polyethyleneglycol on Hepatic Metastasis Model Mice and Evaluation Using a Fluorescent Imaging Device.
Sugiyama I; Oikawa H; Masuda T; Sadzuka Y
Curr Drug Deliv; 2017; 14(5):668-675. PubMed ID: 27017825
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
[TBL] [Abstract][Full Text] [Related]
17. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
18. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
19. Well-Defined Redox-Sensitive Polyethene Glycol-Paclitaxel Prodrug Conjugate for Tumor-Specific Delivery of Paclitaxel Using Octreotide for Tumor Targeting.
Yin T; Wu Q; Wang L; Yin L; Zhou J; Huo M
Mol Pharm; 2015 Aug; 12(8):3020-31. PubMed ID: 26086430
[TBL] [Abstract][Full Text] [Related]
20. Efficient Anti-Glioma Therapy Through the Brain-Targeted RVG15-Modified Liposomes Loading Paclitaxel-Cholesterol Complex.
Xin X; Liu W; Zhang ZA; Han Y; Qi LL; Zhang YY; Zhang XT; Duan HX; Chen LQ; Jin MJ; Wang QM; Gao ZG; Huang W
Int J Nanomedicine; 2021; 16():5755-5776. PubMed ID: 34471351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]